Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4

2(66.7%)

N/A

1(33.3%)

3Total

Phase 4(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06948864Completed

Evaluate the Outcomes of Ferric Carboxymaltose in Patients With Perioperative Anemia

Role: lead

NCT03728452Completed

Trophic Nutrition in Patients Submitted to High Flow Oxygen Therapy and / or Non Invasive Mechanical Ventilation

Role: collaborator

NCT04379258Completed

Analysis of Mortality of Critically Ill Patients With COVID-19

Role: collaborator

NCT04154761Completed

Resection of the Inferior Vena Cava Due to Tumor Involvement

Role: lead

NCT02620358Not ApplicableCompleted

Two Opposite Strategies of Weaning From Mechanical Ventilation

Role: collaborator

NCT01489891Phase 4Completed

Usefulness of Lidocaine as Topical Pharyngeal Anaesthesia in Esophagogastroduodenoscopy Under Sedation With Propofol

Role: lead

NCT01510509Phase 4Unknown

The Titan Versus Everolimus Intracoronary Stent (Xience V) in Diabetic Patients

Role: lead

All 7 trials loaded